| 标题 |
 868P Phase II trial of ozuriftamab vedotin (BA3021), a conditionally active biologic (CAB)-ROR2-ADC, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Annals of Oncology 作者：W. Wong; D.R. Adkins; J.G. Misleh; J. Lorch; J.S. Grewal; et al 出版日期：2024-09-18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
清爽老九
嘉心糖
学霸业
GingerF
OK
Criminology34
aa
111zzzzzz
嘻嘻哈哈
MchemG
herococa
wyc
学术文献互助
agathahqs
今夕何夕
无极微光
渡人舟
Lifeismovie
倘若回到最初
愉快的真
皖公网安备34019202002308
